Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Sakar Healthcare Business Update

Sakar Healthcare says its oncology export model is expanding, with 22 Marketing Authorizations granted and commercial supply starting from its EU GMP site. No monetary value stated.

Source

NSE filing, NSE: SAKAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sakar Healthcare Ltd: key numbers

Share price
₹989.00
Market cap
₹2,201 Cr
Revenue (annual)
₹251.7 Cr
Net profit (annual)
₹30.48 Cr
P/E (TTM)
51.3×Sector 46.1×
Promoter holding
51.70%-0.82% QoQ
FII holding
12.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sakar Healthcare Ltd

All →

Other business update announcements

All →